Wednesday, August 8, 2018 from 11:30 AM to 1:30 PM EDT
Add to Calendar 


UConn Health
Technology Incubation Program Building
Grossman Auditorium 
400 Farmington Ave.
Farmington, CT 06032

Driving Directions 

Event Contact

Paige Rasid 
UConn Technology Commercialization Services 

Thank you to our Sponsor

This event is supported by 
Hamilton Brook Smith Reynolds

HBSR logo

About UConn's Technology Commercialization Services

The mission of Technology Commercialization Services is to expedite and facilitate the transformation of UConn discoveries into products and services that benefit society.

Our goals are to bring together UConn researchers and the business community in order to significantly enhance the commercial and societal impact of UConn’s research; identify and help move inventions by UConn faculty, staff and students towards the market through licensing, or new company formation; secure patent protection for new technologies, where warranted by market forces; generate industrial support for ongoing applied/translational research projects.

Contact us to evaluate and protect a UConn invention; find proof of concept and/or startup funding at UConn, from the investment community, as well as state and private sources; receive coaching and mentoring for your new venture; start a company; license a technology; incubate your business at UConn; access University-wide programs supporting innovation and entrepreneurship.

For more information, please visit: http://research.uconn.edu/technology-commercialization

Successful Commercialization 
of your Innovation 

Seminar and Lunch on August 8 at UConn Health

Luck is where preparation meets opportunity. 

In this unique seminar, an in-licensing officer from Novo Nordisk and patent attorneys from Hamilton Brook Smith Reynolds will present topics to increase your understanding of what industry wants and the patent system requires to position your innovation for successful commercialization.  UConn’s Technology Commercialization Services will describe its role in facilitating that success.

Key topics:

  • What timing issues should I consider after I recognize my innovation?
  • What are the first steps I should take to avoid accidental pitfalls?
  • What details should I develop and describe to increase the likelihood of obtaining an enforceable, valid patent?
  • What data should I provide to maximize the commercial value of my innovation?
  • When should I speak to potential partners?
  • How much information should I share with potential partners?
  • What is my time commitment during the licensing process and the patenting process?

The presentation will be followed by Q & A and
a networking lunch in the Cafe.

Featured Speakers

Aaron Schwartz

Aaron Schwartz
Director, Search & Evaluation, Global Drug Discovery
Novo Nordisk

Aaron has been a Director in Novo Nordisk’s Search & Evaluation team in Global Drug Discovery  since 2016.  In this capacity, Aaron is responsible for the search and evaluation of new therapeutics and enabling technologies for protein, peptide, and antibody drugs.  Prior to joining Novo Nordisk, Aaron worked in the MIT Technology Licensing Office for 13.5 years.  During this time, he worked on license and sponsored research agreements with life sciences companies from startups to big biotech/pharma and everything in between.  He also managed a portfolio of over 650 technologies.  Before Aaron’s time at MIT, he was a management consultant to big pharma and a startup.  Aaron has an undergraduate degree in biology from the University of Chicago and a Masters degree in biology from MIT.
Deirdre Sanders

Deirdre E. Sanders
Principal Attorney, Life Sciences
Hamilton Brook Smith Reynolds

Deirdre has 20+ years of experience in strategic biotechnology patent prosecution counseling and in intellectual property litigation and enforcement.  She is dedicated to guiding clients through the development, management, and protection of intellectual property rights to achieve their business goals. Deirdre’s patent practice is focused in the field of biotechnology with a particular emphasis in the areas of biologics including antibody-based therapeutics, pharmaceuticals, immuno-oncology and immunotherapy, vaccines, microbiomes, bioinformatics, protein-based sensors, and drug discovery and development.

Mark Solomon Mark B. Solomon
Principal Attorney, Engineering
Hamilton Brook Smith Reynolds

Mark’s 20 years in patent law complements his 10 years as an electrical and control systems engineer, which he uses in guiding companies and universities through the development, management, protection, and enforcement of intellectual property rights. He provides high value IP services for clients who value IP by drafting and prosecuting patent applications from strategic business or licensing perspectives. Mark’s technical background includes diverse engineering technologies, such as motion control systems, process control systems, medical devices, mechanical devices, robotics, autonomous vehicles, telecommunications, optics and opto-electronics, signal processing, image processing, voice processing, optical networking and electrical networking, business methods, analog electronics and digital electronics, software, GPS systems, antennas, mobile devices, nano-materials, semiconductors, fuel cells and other renewable energy systems, artificial intelligence such as neural networks, and the Internet-of-Things.

This event is free for participants.  Space may be limited and pre-registration is required.  

If you require an accommodation to participate in this event, please contact

Paige Rasid, OVPR at 860-486-8718 or email: paigerasid@uconn.edu by (8/1/18).
TCS Is a unit of the Office of the Vice President for Research

UConn Research Logo